Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
iScience ; 26(2): 105932, 2023 Feb 17.
Artículo en Inglés | MEDLINE | ID: mdl-36698722

RESUMEN

A better understanding of the molecular mechanism involving the lncRNA-miRNA-mRNA network underlying radiation damage can be beneficial for radioprotection. This study was designed to investigate the potential role of lncRNA NEAT1, miR-147 and Phosphoinositide Dependent Protein Kinase 1 (PDPK1) interaction in radioprotection by troxerutin (TRT). We first demonstrated that NEAT1 sponged miR-147, and PDPK1 mRNA was the primary target of miR-147. In the cells, the NEAT1 and PDPK1 levels were downregulated after the radiation but increased after the treatment with TRT. The miR-147 level was significantly induced by radiation and inhibited by TRT. NEAT1 negatively regulated the expression of miR-147, whereas miR-47 targeted PDPK1 to downregulate its expression. In radioprotection, TRT effectively upregulated NEAT1 to inhibit miR-147 and to upregulate PDPK1. We concluded that TRT could promote radioprotection by stimulating NEAT1 to upregulate PDPK1 expression by suppressing miR-147. NEAT1 could be a critical therapeutic target of radiation damage.

2.
Phytomedicine ; 104: 154317, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35816993

RESUMEN

BACKGROUND: In response to radiation injury, p65 becomes activated. The formation of p65 is one target of Onjisaponin B (OB), but it has not been studied in radioprotection. In addition, there is a binding site for p65 in the promoter region of Cas3. This study evaluates the use of OB as an intervention to modulate p65/Cas3 following radiation exposure. PURPOSE: This study aimed to confirm that OB regulated the transcription of Cas3 via p65 to overcome radiation-induced damage. STUDY DESIGN AND METHODS: Cells and mice were exposed to X-rays at a dose of 6 Gy. Immunofluorescence was used to locate intracellular p65. For the protein and mRNA analyses, Western blotting and RT-qPCR-based assays were conducted accordingly. HE staining was used to observe pathological changes in tissues. DNA damage was detected by the comet assay and DNA ladder assay. Next, apoptosis was detected by flow cytometry and Hoechst staining. RESULTS: Compared with the radiation group, the expression levels of p-p65 and c-Cas3 in the drug group were significantly down-regulated by OB 20 µg/ml. When the expression of p65 was suppressed in V79 and TC cells, OB did not significantly inhibit the activation of p65 or Cas3 in response to irradiation, nor did it significantly inhibit the phosphorylation of p65 and subsequent nuclear translocation. Overexpression of p65 in V79 and MTEC-1 cells resulted in OB significantly inhibiting the activation of p65 and Cas3, and the phosphorylation and translocation of p65 into the nucleus. At 3 d for V79 cells and 24 h for MTEC-1 cells after radiation, compared with the Cas3 over plasmid transfection group, the drug transfection group had no significant effect on reducing apoptosis. In p65+/- mice, expression of the p65 gene was knocked down, leading to increased tissue apoptosis and inflammation, and serious tissue pathological changes. The inhibition of p65 activation by OB after radiation exposure was not apparent in the thymus, although it was observed in the lung. CONCLUSIONS: OB interfered with radiation injury by targeting and regulating p65/Cas3. Therefore, it has been concluded that p65 is an important target molecule for the treatment of radiation injury.


Asunto(s)
Proteínas Asociadas a CRISPR , Traumatismos por Radiación , Animales , Apoptosis , Proteínas Asociadas a CRISPR/metabolismo , Proteínas Asociadas a CRISPR/farmacología , Ratones , FN-kappa B/metabolismo , Fosforilación , Saponinas , Factor de Transcripción ReIA/metabolismo , Triterpenos
3.
EJNMMI Res ; 9(1): 92, 2019 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-31535286

RESUMEN

BACKGROUND: Methamphetamine (METH)-associated alterations in the striatal dopamine (DA) system or dopamine transport (DAT) have been identified in clinical and preclinical studies with positron emission tomography (PET) imaging but have not been well correlated with in vivo serotonin transporter (SERT) availability due to the lack of appropriate imaging agents to assess SERTs. N,N-dimethyl-2-(2-amino-4-[18F]-fluorophenylthio) benzylamine (4-[18F]-ADAM) has been developed by our group and validated for its high affinity and selectivity for SERTs, allowing the in vivo examination of SERT density, location, and binding function. The aims of this study were to investigate the potential of SERT imaging using 4-[18F]-ADAM PET to estimate the long-lasting effects of METH-induced serotonergic neurotoxicity, and further determine whether a correlative relationship exists between SERT availability/activity and tyrosine hydroxylase (TH) activity in various brain regions due to the long-lasting consequences of METH treatment. RESULTS: Male rats received four administrations of METH (5 or 10 mg/kg, s.c.) or saline (1 ml/kg, s.c.) at 1-h intervals. At 30 days post-administration, in vivo SERT availability and activity were measured by 4-[18F]ADAM PET imaging. In contrast to the controls, the uptake of 4-[18F]ADAM in METH-treated mice was significantly reduced in a dose-dependent manner in the midbrain, followed by the hypothalamus, thalamus, striatum, hippocampus, and frontal cortex. The regional effects of METH on TH activity were assessed by quantitative immunohistochemistry and presented as integrated optical density (IOD). A significant decrease in TH immunostaining and IOD ratios was seen in the caudate, putamen, nucleus accumbens, substantia nigra pars compacta, and substantia nigra pars reticulata in the METH-treated rats compared to controls. CONCLUSION: The present results suggested that the long-lasting response to METH decreased the uptake of 4-[18F]-ADAM and varied regionally along with TH immunoreactivity. In addition, 4-[18F]ADAM PET could be used to detect serotonergic neuron loss and to evaluate the severity of serotonergic neurotoxicity of METH.

4.
EJNMMI Res ; 4(1): 71, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26116128

RESUMEN

BACKGROUND: [(18) F]AFM is a potent and promising PET imaging agent for the serotonin transporter. We carried out an acute toxicity study in rats and radiation dosimetry in monkeys before the translation of the tracer to humans. METHODS: Single- and multiple-dose toxicity studies were conducted in Sprague-Dawley rats. Male and female rats were injected intravenously with AFM tartrate as a single dose of 98.7 or 987 µg/kg (592 or 5,920 µg/m(2), 100× or 1,000× the proposed human dose of 8 µg, respectively) on day 1 or as five consecutive daily doses of 98.7 µg/kg/day (592 µg /m(2)/day, 100× human dose, total dose 493.5 µg/kg). PET/CT scans were performed in four Formosan rock monkeys (two males and two females, each monkey scanned twice) using a Siemens BIOGRAPH scanner. After injection of [(18) F]AFM (88.5 ± 20.3 MBq), a low-dose CT scan and a series of eight whole-body PET scans in 3-D mode were performed. Time-activity data of source organs were used to calculate the residence times and estimate the absorbed radiation dose using the OLINDA/EXM software. RESULTS: In the rats, neither the single dose nor the five daily doses of AFM tartrate produced overt adverse effects clinically. In the monkeys, the radiation doses received by most organs ranged between 8.3 and 39.1 µGy/MBq. The osteogenic cells, red marrow, and lungs received the highest doses of 39.1, 35.4, and 35.1 µGy/MBq, respectively. The effective doses extrapolated to male and female adult humans were 18.0 and 18.3 µSv/MBq, respectively. CONCLUSIONS: Toxicity studies in Sprague-Dawley rats and radiation dosimetry studies in Formosa rock monkeys suggest that [(18) F]AFM is safe for use in human PET imaging studies. TRIAL REGISTRATION: IACUC-12-200.

5.
Appl Ergon ; 44(1): 134-41, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22770544

RESUMEN

BACKGROUND: Early intervention educators who serve children with special needs often suffer from physical strains. The objectives of this study were to investigate the prevalence of work-related musculoskeletal disorders in this population, and to evaluate the relationship between work-related musculoskeletal disorders and personal/ergonomic risk factors. METHODS: A self-designed questionnaire consisting three domains (demographics/prevalence of work-related musculoskeletal disorders/ergonomic risk factors) was delivered to educators who work in early intervention institutions. RESULTS: Ninety-four percent of early intervention educators suffered from musculoskeletal disorders. Logistic regression revealed that some work-related ergonomic factors were highly associated with symptoms on lower back, shoulder and neck, with odds ratios ranging from 0.321 to 4.256. CONCLUSION: High prevalence of work-related musculoskeletal disorders impacts this occupation negatively. Further regulations to the institutions regarding workplace health promotion and environment modification, as well as training to the employees for body mechanics, should be implemented to prevent injury occurrence.


Asunto(s)
Intervención Educativa Precoz , Ergonomía , Docentes , Enfermedades Musculoesqueléticas/epidemiología , Enfermedades Profesionales/epidemiología , Exposición Profesional/análisis , Adulto , Femenino , Humanos , Masculino , Enfermedades Musculoesqueléticas/etiología , Enfermedades Profesionales/etiología , Prevalencia , Análisis de Regresión , Factores de Riesgo , Encuestas y Cuestionarios , Taiwán/epidemiología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA